Neurological manifestations in patients with symptomatic COVID-19 admitted to the Bafoussam Regional Hospital, Cameroon
INTRODUCTION: although the main manifestations of COVID-19 are respiratory, several neurological symptoms and complications have also been reported. The pandemic seems to have some epidemiological specificities in sub-Saharan Africa, and this may be reflected in the type and frequency of neurological symptoms. This study aimed to report neurological manifestations associated with symptomatic COVID-19 in a sub-Saharan African setting. METHODS: we conducted a retrospective review of symptomatic PCR-confirmed COVID-19 cases admitted to the Bafoussam Regional Hospital between March and September 2020. Patients’ files were reviewed at discharge by a consultant neurologist. Socio-demographic characteristics, co-morbidities, symptoms on admission, neurological symptoms during hospitalization, management, and in-hospital outcome were recorded. Comparisons between patients with and without neurological symptoms were performed using Fisher’s exact and Mann-Whitney U test. RESULTS: we enrolled 177 symptomatic patients (68% men). Mean age was 54.6 ± 17.8 years (range 2-99 years). Co-morbidities were present in 57.6% of patients, including hypertension (27.1%) and diabetes mellitus (25.4%). Neurological symptoms were found in 113 (63.8%) patients. The most frequent were headache (39.0%), myalgia (35.6%), anosmia (11.9%), impaired consciousness (10.7%) and delirium (5.6%). Regarding the presenting symptoms, fever was more frequent in patients with neurological symptoms than in those without (81.4% versus 50.0%, p= 0.001), while digestive symptoms were less frequent in patients with neurological symptoms (0.9% versus 9.4%, p= 0.004). CONCLUSION: neurological manifestations are frequent and heterogeneous in patients with symptomatic COVID-19. Further studies are needed to clarify the pathophysiology of neurological symptoms in COVID-19 and their impact on patients’ long-term outcome..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
The Pan African Medical Journal - 38(2021), 326 Zur Gesamtaufnahme - volume:38 |
|---|
| Sprache: |
Englisch ; Französisch |
|---|
| Beteiligte Personen: |
Yannick Fogoum Fogang [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.11604/pamj.2021.38.326.28973 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ00369920X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ00369920X | ||
| 003 | DE-627 | ||
| 005 | 20230503105511.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.11604/pamj.2021.38.326.28973 |2 doi | |
| 035 | |a (DE-627)DOAJ00369920X | ||
| 035 | |a (DE-599)DOAJc50077ebf48d444993b6ce32c8ca597d | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a fre | ||
| 100 | 0 | |a Yannick Fogoum Fogang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neurological manifestations in patients with symptomatic COVID-19 admitted to the Bafoussam Regional Hospital, Cameroon |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a INTRODUCTION: although the main manifestations of COVID-19 are respiratory, several neurological symptoms and complications have also been reported. The pandemic seems to have some epidemiological specificities in sub-Saharan Africa, and this may be reflected in the type and frequency of neurological symptoms. This study aimed to report neurological manifestations associated with symptomatic COVID-19 in a sub-Saharan African setting. METHODS: we conducted a retrospective review of symptomatic PCR-confirmed COVID-19 cases admitted to the Bafoussam Regional Hospital between March and September 2020. Patients’ files were reviewed at discharge by a consultant neurologist. Socio-demographic characteristics, co-morbidities, symptoms on admission, neurological symptoms during hospitalization, management, and in-hospital outcome were recorded. Comparisons between patients with and without neurological symptoms were performed using Fisher’s exact and Mann-Whitney U test. RESULTS: we enrolled 177 symptomatic patients (68% men). Mean age was 54.6 ± 17.8 years (range 2-99 years). Co-morbidities were present in 57.6% of patients, including hypertension (27.1%) and diabetes mellitus (25.4%). Neurological symptoms were found in 113 (63.8%) patients. The most frequent were headache (39.0%), myalgia (35.6%), anosmia (11.9%), impaired consciousness (10.7%) and delirium (5.6%). Regarding the presenting symptoms, fever was more frequent in patients with neurological symptoms than in those without (81.4% versus 50.0%, p= 0.001), while digestive symptoms were less frequent in patients with neurological symptoms (0.9% versus 9.4%, p= 0.004). CONCLUSION: neurological manifestations are frequent and heterogeneous in patients with symptomatic COVID-19. Further studies are needed to clarify the pathophysiology of neurological symptoms in COVID-19 and their impact on patients’ long-term outcome. | ||
| 650 | 4 | |a coronavirus | |
| 650 | 4 | |a headache | |
| 650 | 4 | |a anosmia | |
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a africa | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a Michel Noubom |e verfasserin |4 aut | |
| 700 | 0 | |a Pierre-Yves Bassong |e verfasserin |4 aut | |
| 700 | 0 | |a Paul Chimi Mbonda |e verfasserin |4 aut | |
| 700 | 0 | |a Iliassou Njoudap Mfopou |e verfasserin |4 aut | |
| 700 | 0 | |a Daniel Massi Gams |e verfasserin |4 aut | |
| 700 | 0 | |a Callixte Tegueu Kuate |e verfasserin |4 aut | |
| 700 | 0 | |a Joseph Kamtchum-Tatuene |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t The Pan African Medical Journal |g 38(2021), 326 |
| 773 | 1 | 8 | |g volume:38 |g year:2021 |g number:326 |
| 856 | 4 | 0 | |u https://doi.org/10.11604/pamj.2021.38.326.28973 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/c50077ebf48d444993b6ce32c8ca597d |z kostenfrei |
| 856 | 4 | 0 | |u https://www.panafrican-med-journal.com/content/article/38/326/pdf/326.pdf |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1937-8688 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1937-8688 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2021 |e 326 | ||